India, Sept. 19 -- The final phase of human clinical trial of Oxford-Astrazeneca's Covishield will begin at the Sasson General Hospital in Pune next week, after Drugs Controller General of India gave Serum Institute of India (SII) a go-ahead to continue its trial.

"The phase-III trial of 'Covishield' vaccine will begin at Sassoon hospital from next week. It is likely to start on Monday. Some volunteers have already come forward for the trial. Around 150 to 200 volunteers will be administered the vaccine candidate dose," Dr Muralidhar Tambe, dean of Sassoon General Hospital, told PTI.

Also Read | AstraZeneca's trial illnesses may not be due to Covid-19 shot, says Oxford University

Here is a timeline of the Covishield trial in India

* O...